NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
4.09
Dollar change
+0.23
Percentage change
5.96
%
Index- P/E54.17 EPS (ttm)0.08 Insider Own12.87% Shs Outstand10.60M Perf Week-4.66%
Market Cap43.36M Forward P/E409.00 EPS next Y0.01 Insider Trans0.00% Shs Float9.24M Perf Month55.52%
Enterprise Value40.61M PEG- EPS next Q-0.03 Inst Own44.00% Short Float0.07% Perf Quarter144.91%
Income0.80M P/S2.79 EPS this Y-50.00% Inst Trans-1.00% Short Ratio0.20 Perf Half Y175.42%
Sales15.52M P/B4.67 EPS next Y100.00% ROA6.91% Short Interest0.01M Perf YTD178.23%
Book/sh0.88 P/C10.63 EPS next 5Y- ROE9.17% 52W High5.00 -18.20% Perf Year95.69%
Cash/sh0.38 P/FCF96.35 EPS past 3/5Y- - ROIC7.81% 52W Low1.36 199.79% Perf 3Y127.22%
Dividend Est.- EV/EBITDA44.14 Sales past 3/5Y11.50% 6.51% Gross Margin61.54% Volatility8.29% 12.62% Perf 5Y-49.51%
Dividend TTM- EV/Sales2.62 EPS Y/Y TTM154.94% Oper. Margin4.98% ATR (14)0.44 Perf 10Y-31.13%
Dividend Ex-Date- Quick Ratio4.64 Sales Y/Y TTM10.34% Profit Margin5.16% RSI (14)57.78 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio5.92 EPS Q/Q426.71% SMA207.00% Beta1.06 Target Price4.75
Payout0.00% Debt/Eq0.14 Sales Q/Q38.47% SMA5044.59% Rel Volume2.00 Prev Close3.86
Employees31 LT Debt/Eq0.10 EarningsMay 08 BMO SMA200114.42% Avg Volume32.50K Price4.09
IPOSep 21, 2004 Option/ShortNo / Yes EPS/Sales Surpr.1100.00% 33.56% Trades Volume64,926 Change5.96%
Date Action Analyst Rating Change Price Target Change
Jan-26-21Initiated B. Riley Securities Buy $12.50
May-28-25 09:00AM
May-08-25 04:00PM
May-07-25 11:46AM
Apr-30-25 04:00PM
Apr-28-25 09:00AM
04:00PM Loading…
Mar-06-25 04:00PM
Mar-05-25 07:36AM
Feb-26-25 04:00PM
Dec-04-24 09:00AM
Nov-08-24 04:03PM
Nov-07-24 04:01PM
Nov-06-24 07:56AM
Oct-31-24 07:30AM
Oct-25-24 09:10AM
Oct-24-24 09:00AM
09:00AM Loading…
Oct-17-24 09:00AM
Oct-09-24 05:56PM
Aug-08-24 04:01PM
Aug-01-24 07:30AM
May-09-24 04:15PM
May-02-24 07:30AM
Apr-29-24 09:00AM
Apr-23-24 07:30AM
Mar-08-24 01:01PM
Mar-07-24 04:15PM
Feb-29-24 04:30PM
Nov-11-23 12:41PM
Nov-08-23 04:15PM
Nov-01-23 07:30AM
Oct-25-23 07:30AM
04:30PM Loading…
Sep-19-23 04:30PM
Aug-09-23 04:15PM
Jul-26-23 07:30AM
May-24-23 07:30AM
May-10-23 04:15PM
May-08-23 07:30AM
Apr-26-23 07:30AM
Apr-04-23 07:30AM
Mar-08-23 04:15PM
Mar-01-23 04:30PM
Feb-22-23 04:30PM
Jan-11-23 07:30AM
Nov-02-22 04:15PM
Oct-19-22 07:30AM
Oct-12-22 07:30AM
Oct-11-22 07:30AM
Sep-28-22 07:30AM
Sep-08-22 04:00PM
Aug-13-22 08:22AM
Aug-10-22 04:15PM
Jul-27-22 07:30AM
Jul-06-22 07:30AM
May-17-22 07:30AM
May-04-22 04:15PM
Apr-27-22 07:30AM
Apr-26-22 07:30AM
Mar-21-22 07:30AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Feb-09-22 07:30AM
Jan-13-22 07:30AM
Jan-11-22 07:30AM
Nov-23-21 04:15PM
Nov-08-21 07:30AM
Nov-04-21 04:15PM
Oct-21-21 07:30AM
Oct-08-21 07:30AM
Oct-05-21 07:30AM
Sep-15-21 09:39AM
Sep-06-21 11:42AM
Sep-01-21 07:30AM
Aug-05-21 04:15PM
Jul-28-21 03:03PM
Jul-12-21 07:30AM
Jul-09-21 04:18PM
Jul-08-21 11:20AM
07:30AM
05:07AM
Jun-29-21 08:50AM
Jun-23-21 09:35AM
May-31-21 08:50AM
May-06-21 04:15PM
02:45PM
Apr-26-21 07:30AM
Apr-09-21 05:29AM
Apr-05-21 07:30AM
Mar-16-21 07:45AM
Mar-10-21 07:30AM
Mar-04-21 02:07AM
Mar-01-21 04:15PM
02:30PM
Feb-22-21 07:30AM
Feb-18-21 07:30AM
Jan-22-21 02:21AM
Jan-12-21 07:30AM
Jan-05-21 10:55AM
Jan-04-21 07:30AM
Nov-29-20 09:33AM
Nov-19-20 06:45AM
Nov-09-20 07:30AM
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.